Ligand Pharmaceuticals — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Athiraathira.comDec 2025

A biotechnology company developing new therapies for patients with high unmet medical needs.

Biotech

Co-investorsDolby Family Ventures LifeSci Venture Partners Sofinnova Ventures The W Fund Commodore Capital Franklin Templeton +5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.